From January 4, 2024 to March 31, 2024, the company has repurchased 2,025,200 shares, representing 0.23% for CNY 40 million. With this, the company has completed the repurchase of 2,025,200 shares, representing 0.23% for CNY 40 million under the buyback announced on January 5, 2024.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
16.11 CNY | +3.27% | +8.56% | -33.46% |
EPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-33.46% | 2B | |
+26.47% | 664B | |
+26.74% | 567B | |
-6.33% | 354B | |
+19.35% | 330B | |
+4.23% | 286B | |
+13.43% | 234B | |
+4.71% | 199B | |
-9.53% | 196B | |
-4.04% | 148B |
- Stock Market
- Equities
- 603456 Stock
- News Zhejiang Jiuzhou Pharmaceutical Co., Ltd
- Tranche Update on Zhejiang Jiuzhou Pharmaceutical Co., Ltd's Equity Buyback Plan announced on January 5, 2024.